|Articles|October 14, 2019
SEC-MALS Method for Characterizing mRNA Biophysical Attributes
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
3
Industry Outlook 2026: How AI and Payer Pressure Impact Biopharma R&D (Part 1)
4
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
5